Financials
| Half-year Report | Sep. 30, 2025 |
| Annual financial statements 2024 | May. 07, 2025 |
| Final Results | Apr. 30, 2025 |
| Half-year Report | Sep. 30, 2024 |
| Audited Financial Statements Year Ended 2023 | May. 07, 2024 |
| Full Text of Accounts | May. 07, 2024 |
| Final Results | May. 07, 2024 |
Proxies
| Result of AGM | Jun. 12, 2025 |
| AGM Notice | May. 22, 2025 |
| Print of Ordinary and Special Resolutions | Jun. 28, 2024 |
| Result of AGM | Jun. 27, 2024 |
| Notice of AGM | Jun. 03, 2024 |
| Notice of Annual General Meeting | May. 16, 2023 |
| Results of AGM | Jun. 14, 2022 |
Ownership Update
| Update, Equity Issue and PDMR Notification | Oct. 09, 2025 |
| Holding(s) in Company | Sep. 19, 2025 |
| Holding(s) in Company | Aug. 27, 2025 |
| Holding(s) in Company | May. 12, 2025 |
| Holding in Company | Mar. 28, 2025 |
| Director Dealings | Mar. 28, 2025 |
| Holding(s) in Company | Jan. 13, 2025 |
Announcements
| Recognition of Patentability of Claims | Oct. 20, 2025 |
| Update on Animal Health Program | Oct. 10, 2025 |
| Issue of Equity - Correction | Oct. 02, 2025 |
| Issue of Equity | Oct. 02, 2025 |
| Genflow Signs CDAs with Animal Health Companies | Sep. 15, 2025 |
| Company Update on Dog Trials | Aug. 18, 2025 |
| Clinical Readiness Acceleration | Jul. 24, 2025 |
Prospectuses
| GENFLOW BIOSCIENCES PLC - Single prospectus | Jan. 07, 2022 |